Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients Treated for Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT00907036
What this trial is testing

Fludarabine Phosphate, Melphalan, and Alemtuzumab Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed Hodgkin Lymphoma

Who this might be right for
Lymphoma
Cancer Research UK 49
Not applicableLooking for participantsNCT07309211
What this trial is testing

Durvalumab as Consolidation Therapy in Patients With LS-SCLC Following sCRT

Who this might be right for
SCLC, Limited Stage
The First Affiliated Hospital with Nanjing Medical University 25
Large-scale testing (Phase 3)Active Not RecruitingNCT04068103
What this trial is testing

Circulating Tumor DNA Testing in Predicting Treatment for Patients With Stage IIA Colon Cancer After Surgery

Who this might be right for
Colon AdenocarcinomaStage IIA Colon Cancer AJCC v8
NRG Oncology 635
Not applicableWithdrawnNCT02370342
What this trial is testing

Robot-Assisted Ultrasound for Thermal Ablative Therapy in Treating Patients With Small Kidney Masses Undergoing Surgery

Who this might be right for
Renal CarcinomaRenal Mass
University of Southern California
Not applicableStudy completedNCT01503541
What this trial is testing

S9031-9333-0106-0112-A Study of Biomarkers in Samples From Patients With Acute Myeloid Leukemia Treated With Standard Chemotherapy With or Without Gemtuzumab Ozogamicin

Who this might be right for
Leukemia
SWOG Cancer Research Network 365
Testing effectiveness (Phase 2)Active Not RecruitingNCT02397083
What this trial is testing

Levonorgestrel-Releasing Intrauterine System With or Without Everolimus in Treating Patients With Atypical Hyperplasia or Stage IA Grade 1 Endometrial Cancer

Who this might be right for
Atypical Endometrial HyperplasiaFIGO Grade 1 Endometrial Endometrioid AdenocarcinomaFIGO Grade 2 Endometrial Endometrioid Adenocarcinoma
M.D. Anderson Cancer Center 102
Testing effectiveness (Phase 2)Looking for participantsNCT07228273
What this trial is testing

Induction and Consolidation With Fludarabine, Cytarabine, Idarubicin, and Venetoclax for the Treatment of Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndrome
OHSU Knight Cancer Institute 102
Early research (Phase 1)Study completedNCT00357305
What this trial is testing

Vorinostat, Cytarabine, and Etoposide in Treating Patients With Relapsed and/or Refractory Acute Leukemia or Myelodysplastic Syndromes or Myeloproliferative Disorders

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Basophilic LeukemiaAdult Acute Eosinophilic Leukemia+31 more
National Cancer Institute (NCI) 25
Testing effectiveness (Phase 2)WithdrawnNCT00242931
What this trial is testing

Flu/TBI in Treating Patients Not Responding to Previous Hormone Therapy

Who this might be right for
Prostate Cancer
OHSU Knight Cancer Institute
Large-scale testing (Phase 3)Study completedNCT03285802
What this trial is testing

Treatment Plan for an Individual Patient With Recurrent Uterine Papillary Serous Carcinoma (UPSC) With PIK3CA Gene Mutation

Who this might be right for
Uterine Cancer
Greater Baltimore Medical Center 1
Testing effectiveness (Phase 2)Study completedNCT00002657
What this trial is testing

SWOG-9239 Reduction of Immunosuppression Plus Interferon Alfa and Combination Chemotherapy in Treating Patients With Malignant Tumors That Develop After Organ Transplant

Who this might be right for
LymphomaMultiple Myeloma and Plasma Cell Neoplasm
SWOG Cancer Research Network 20
Testing effectiveness (Phase 2)WithdrawnNCT00025519
What this trial is testing

Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Recurrent Kidney Cancer

Who this might be right for
Kidney Cancer
Fox Chase Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00002792
What this trial is testing

Combination Chemotherapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Myeloproliferative Disorders

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaMyelodysplastic/Myeloproliferative Diseases
Fred Hutchinson Cancer Center 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT03671811
What this trial is testing

Megestrol Acetate With or Without Pterostilbene in Treating Patients With Endometrial Cancer Undergoing Hysterectomy

Who this might be right for
Atypical Endometrial HyperplasiaEndometrial Carcinoma
City of Hope Medical Center 44
Testing effectiveness (Phase 2)UnknownNCT03830411
What this trial is testing

Sintilimab Compared With Docetaxel or Pemetrexed as Second-line Treatment for Patients With Stage IV Nonsquamous Non-small Cell Lung Cancer After Failure With Platinum-Containing Chemotherapy

Who this might be right for
Nonsquamous Non-Small Cell Lung Cancer
Xin-Hua Xu 76
Testing effectiveness (Phase 2)Ended earlyNCT02663271
What this trial is testing

TTFields and Pulsed Bevacizumab for Recurrent Glioblastoma

Who this might be right for
Glioblastoma MultiformeGlioblastomaMalignant Glioma+1 more
University of Florida 10
Not applicableStudy completedNCT00483639
What this trial is testing

Study of Anxiety and Avoidance of Others in Patients Previously Treated for Head and Neck Cancer

Who this might be right for
Anxiety DisorderHead and Neck CancerLung Cancer
Vanderbilt-Ingram Cancer Center 100
Post-approval studies (Phase 4)Study completedNCT00883675
What this trial is testing

Safety Study of Adjuvant Docetaxel-Carboplatin Treatment for Resected Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Michael Mann 133
Testing effectiveness (Phase 2)Study completedNCT01100528
What this trial is testing

Dacarbazine and Recombinant Interferon Alfa-2b in Treating Patients With Primary Uveal Melanoma With Genetic Imbalance

Who this might be right for
Ciliary Body and Choroid Melanoma, Medium/Large SizeCiliary Body and Choroid Melanoma, Small SizeIris Melanoma+1 more
Case Comprehensive Cancer Center 38
Early research (Phase 1)Study completedNCT00287937
What this trial is testing

Vorinostat, Paclitaxel, and Carboplatin in Treating Patients With Advanced or Refractory Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
National Cancer Institute (NCI) 30
Next Page